325 related articles for article (PubMed ID: 23109125)
1. [The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].
Plener PL; Fegert JM; Kölch MG
Z Kinder Jugendpsychiatr Psychother; 2012 Nov; 40(6):365-71. PubMed ID: 23109125
[TBL] [Abstract][Full Text] [Related]
2. A black-box warning for antidepressants in children?
Newman TB
N Engl J Med; 2004 Oct; 351(16):1595-8. PubMed ID: 15483275
[No Abstract] [Full Text] [Related]
3. Antidepressants and children's depression.
Diller L
Am J Psychiatry; 2005 Jun; 162(6):1226-7. PubMed ID: 15930080
[No Abstract] [Full Text] [Related]
4. FDA questions antidepressant safety for children.
Oransky I
Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000
[No Abstract] [Full Text] [Related]
5. Antidepressants and pediatric depression--the risk of doing nothing.
Brent DA
N Engl J Med; 2004 Oct; 351(16):1598-601. PubMed ID: 15483276
[No Abstract] [Full Text] [Related]
6. Antidepressants and suicidality: the basis of controversies.
Marcinko D
Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
[TBL] [Abstract][Full Text] [Related]
7. Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?
Healy D
Can J Psychiatry; 2009 Feb; 54(2):69-71; discussion 76-7. PubMed ID: 19254434
[No Abstract] [Full Text] [Related]
8. The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses.
Leon AC
Am J Psychiatry; 2007 Dec; 164(12):1786-9. PubMed ID: 18056231
[No Abstract] [Full Text] [Related]
9. Youth suicide trends place SSRIs in spotlight.
Behav Healthc Tomorrow; 2004 Feb; 13(1):42-5. PubMed ID: 15002199
[No Abstract] [Full Text] [Related]
10. Pediatric antidepressant use after the black-box warning.
Busch SH; Barry CL
Health Aff (Millwood); 2009; 28(3):724-33. PubMed ID: 19414881
[TBL] [Abstract][Full Text] [Related]
11. The black box warning: decreased prescriptions and increased youth suicide?
Jureidini J
Am J Psychiatry; 2007 Dec; 164(12):1907; author reply 1908-10. PubMed ID: 18056248
[No Abstract] [Full Text] [Related]
12. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.
Giner L; Nichols CM; Zalsman G; Oquendo MA
Int J Adolesc Med Health; 2005; 17(3):211-20. PubMed ID: 16231472
[TBL] [Abstract][Full Text] [Related]
13. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants use in pediatric populations.
Gören JL
Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
[TBL] [Abstract][Full Text] [Related]
15. SSRI prescriptions and the rate of suicide.
Olfson M; Shaffer D
Am J Psychiatry; 2007 Dec; 164(12):1907-8; author reply 1908-10. PubMed ID: 18056247
[No Abstract] [Full Text] [Related]
16. The FDA warning on antidepressants and suicidality--why the controversy?
Stone MB
N Engl J Med; 2014 Oct; 371(18):1668-71. PubMed ID: 25354102
[No Abstract] [Full Text] [Related]
17. Antidepressants' black-box warning--10 years later.
Friedman RA
N Engl J Med; 2014 Oct; 371(18):1666-8. PubMed ID: 25354101
[No Abstract] [Full Text] [Related]
18. Expanding the black box - depression, antidepressants, and the risk of suicide.
Friedman RA; Leon AC
N Engl J Med; 2007 Jun; 356(23):2343-6. PubMed ID: 17485726
[No Abstract] [Full Text] [Related]
19. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
Valuck RJ; Libby AM; Orton HD; Morrato EH; Allen R; Baldessarini RJ
Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
[TBL] [Abstract][Full Text] [Related]
20. Drugs for depression.
Med Lett Drugs Ther; 2016 Jul; 58(1498):85-90. PubMed ID: 27348144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
